Medicare Enrolled
Dr. Edmond Chu, MD
Family Medicine · Anaheim, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chu?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chu
Dr. Edmond Chu is a family medicine specialist in Anaheim, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Chu performed 1,876 Medicare services across 779 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chu received a total of $26,139 from 43 pharmaceutical and/or device companies across 497 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 11% volume in CA
$26,139 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,876
Medicare services
Top 11% in CA for family medicine
779
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~99 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
575 | $96 | $193 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
331 | $63 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
239 | $68 | $124 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
105 | $66 | $131 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
104 | $140 | $200 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
99 | $112 | $280 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
88 | $34 | $160 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
74 | $41 | $120 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
42 | $8 | $11 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
39 | $68 | $180 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
38 | $154 | $337 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 30 | $20 | $45 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
29 | $100 | $293 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
23 | $145 | $360 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
17 | $45 | $85 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
16 | $12 | $70 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
16 | $109 | $260 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $85 | $196 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$26,139
Total received (2018-2024)
Avg $3,734/year across 7 years
Top 1% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
497
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$26,139 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,250
2023
$3,660
2022
$3,116
2021
$3,391
2020
$1,762
2019
$4,915
2018
$5,045
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,408
Gilead Sciences, Inc.
$501
GlaxoSmithKline, LLC.
$483
Lilly USA, LLC
$292
Phathom Pharmaceuticals, Inc.
$238
Boehringer Ingelheim Pharmaceuticals, Inc.
$192
Janssen Pharmaceuticals, Inc
$150
Amgen Inc.
$147
Otsuka America Pharmaceutical, Inc.
$142
SCILEX PHARMACEUTICALS INC.
$141
Ardelyx, Inc.
$137
Vanda Pharmaceuticals Inc.
$125
Axsome Therapeutics, Inc.
$125
Corcept Therapeutics
$115
ABBVIE INC.
$34
Novo Nordisk Inc
$20
Top 3 companies account for 56.3% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$5,781
Janssen Pharmaceuticals, Inc
$3,628
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,412
Novo Nordisk Inc
$2,136
GlaxoSmithKline, LLC.
$2,111
Amgen Inc.
$1,299
Gilead Sciences, Inc.
$1,272
Lilly USA, LLC
$1,054
PFIZER INC.
$942
Amarin Pharma Inc.
$650
SANOFI-AVENTIS U.S. LLC
$504
AbbVie Inc.
$366
Merck Sharp & Dohme Corporation
$354
Corcept Therapeutics
$338
Abbott Laboratories
$281
ABBVIE INC.
$267
Phathom Pharmaceuticals, Inc.
$238
Xeris Pharmaceuticals, Inc.
$237
Allergan Inc.
$170
Biohaven Pharmaceuticals, Inc.
$159
Bayer HealthCare Pharmaceuticals Inc.
$147
Otsuka America Pharmaceutical, Inc.
$142
SCILEX PHARMACEUTICALS INC.
$141
Ardelyx, Inc.
$137
Vanda Pharmaceuticals Inc.
$125
Axsome Therapeutics, Inc.
$125
Radius Health, Inc.
$125
Horizon Pharma plc
$125
ACADIA Pharmaceuticals Inc
$120
CeQur Corporation
$118
Intercept Pharmaceuticals, Inc.
$117
Celgene Corporation
$105
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$100
Almatica Pharma LLC
$74
Allergan, Inc.
$62
Genentech USA, Inc.
$46
CMP Pharma, Inc.
$26
Avanir Pharmaceuticals, Inc.
$24
Kowa Pharmaceuticals America, Inc.
$22
E.R. Squibb & Sons, L.L.C.
$19
Lundbeck LLC
$14
UROVANT SCIENCES INC
$14
Endogastric Solutions, Inc
$11
Top 3 companies account for 45.2% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO · AREXVY · Aimovig · Auvelity · BASAGLAR · BREO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · CHANTIX · CITALOPRAM · Carospir · CeQur Simplicity · ELIQUIS · ELYXYB - CELECOXIB · ESOPHYX · Epclusa · FANAPT · FARXIGA · FASENRA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GEMTESA · GVOKE HYPOPEN · IBSRELA · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · Korlym · LOKELMA · LOREEV XR · Livalo · MAVYRET · MOUNJARO · NUEDEXTA · NUPLAZID · NURTEC ODT · OCALIVA · Otezla · Ozempic · Prolia · QULIPTA · RECORLEV · REXULTI · RYBELSUS · Repatha · RhythmVIEW Work Stations · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNJARDY · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · Tymlos · UBRELVY · VOQUEZNA · VRAYLAR · Vascepa · Vemlidy · Victoza · XARELTO · XIFAXAN · XTANDI · Xofluza · Xultophy 100/3.6
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
3,396
Per 100K population
107.3
County median income
$113,702
Nearest hospital
WEST ANAHEIM MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chu is a clinical cardiology specialist, with above-average Medicare volume (top 11% in CA), with low-engagement industry engagement in the top 1% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chu experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Chu performed 575 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chu receive payments from pharmaceutical companies?
Yes. Dr. Chu received a total of $26,139 from 43 companies across 497 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chu's costs compare to other family medicine physicians in Anaheim?
Dr. Chu's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Anaheim
Browse family medicine physicians in Anaheim ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology